Model Policy Manager, Emerging AI Misuse
OpenAISan FranciscoRemote
53/100 · Fair. Based on age, reposts, pay, the company's hiring and ghost signals.
See the evidence behind this score.
Pro shows each part of the score, the reasons, the pay percentile and the listing history.
HirQ's ghost-risk estimate and company labels are automated opinions based on what we observe on employers' public job boards: how long a listing has been open, whether it was re-listed, wording in the description, and how often roles on that board close. They are not statements about an employer's intent, and a high-risk listing can still be a real opening. Figures are as of the date shown. How we measure
“Boston”
Employer-posted ranges for Science & Research roles in MA in the last 12 months (377 postings).
This job: No pay listed
From Proxima's careers page, checked Nov 22
About Proxima
Proxima is a frontier AI and data generation company discovering the next generation of proximity therapeutics by making protein interactions programmable. Our platform brings together foundation-model machine learning, a scalable data generation engine, and a partnership track record exceeding $5B in collaborations across the world’s leading biopharma and tech organizations. We’ve recently closed an oversubscribed $80M seed round with an elite group of VCs including DCVC, NVIDIA’s NVentures, AIX, Yosemite among others.
Neo-1 is our all-atom foundation model that combines state-of-the-art structure prediction and molecular generation in a single system. Neo-1 enables rapid exploration of chemical and structural space for high value, previously intractable targets, and in particular unlocks small molecule proximity therapeutics like molecular glues with AI for the first time.
In parallel, we are developing an advanced structural interactomics platform built on proprietary XLMS technology and our Boston lab equipped with next-generation mass spectrometry instrumentation. This platform produces proteome-scale maps of protein interactions and helps identify small molecules that modulate proximity. Together with Neo-1, it creates an integrated system capable of co-folding protein complexes while generating candidate small molecules to influence those interactions.
Proximity-based therapeutics represent one of the most promising frontiers in modern drug discovery with the potential to treat previously intractable diseases and target 'undruggable' proteins. Our technology combines proteome-scale structural data with state-of-the-art generative AI foundation models, and coupled with our talented team of scientists and engineers we are uniquely well-positioned to discover and develop a new class of medicines. Come join us!
The Role
What You'll Do
What We're Looking For
Same role or field, nearby or remote, ranked by HirQ score.
OpenAISan FranciscoRemote
American Institutes for ResearchUS-Remote | US-VA-Arlington | US-NC-Chapel Hill | US-IL-Chicago | US-CA-Sacramento | US-TX-AustinRemote
RecursionRemote Opportunity - United States; Salt Lake City, UtahRemote
BasetenSan FranciscoRemote
American Institutes for ResearchUS-RemoteRemote
OpenAISan FranciscoRemote
Director,Chemistry
No pay listed · HirQ 53